Chart of the Week: Rare Disease Activity Sample (LSDs)


We have recently noticed a trend among our customers. We have been successfully addressing some key use cases of our customers focused on rare and orphan diseases. This is an interesting coincidence since rare diseases played such a key role in our recently published report on clinical trial success rates, co-authored with BIO and BioMedTracker(Informa).

As we work with these customers we have become more inspired by what they are pursuing. We have come to realize that with the shifting technologies driving precision medicine the opportunity to serve an under served rare and orphan disease population has never been greater.

In honor of that work we have a tree map of clinical trial activity in a sample of rare diseases in the lysosomal storage diseases space. Specifically this tree map covers Gaucher and Fabry disease.

Are there other rare diseases that you’d like to see?

The information is broken down by disease, organizations working in the disease space (industry and academia), and the relevant biomarkers used by each organization for the disease.



Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access